XML 59 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Convertible Preferred Stock - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 2 Months Ended
Aug. 31, 2021
Apr. 30, 2021
Jul. 31, 2020
Nov. 30, 2020
Sep. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Aug. 10, 2021
Jul. 31, 2021
Jul. 30, 2021
Preferred stock, shares issued (in shares)         0   0     16,944,484
Preferred stock par value (in dollars per share)         $ 0.0001   $ 0.0001      
Common stock, shares issued (in shares)         108,957,401   111,251,660     150,000,000
Common stock, shares authorized (in shares)         1,000,000,000   1,000,000,000   150,000,000  
Preferred stock, shares authorized (in shares)         10,000,000   10,000,000      
Minimum [Member]                    
Common stock, shares authorized (in shares) 150,000,000 19,000,000                
Maximum [Member]                    
Common stock, shares authorized (in shares) 1,000,000,000 23,251,555                
IPO [Member]                    
Undesignated preferred stock capital shares reserved for future issuance               10,000,000    
Convertible preferred stock outstanding converted into common stock 84,722,420                  
IPO [Member] | Minimum [Member]                    
Common stock, shares authorized (in shares)               150,000,000    
IPO [Member] | Maximum [Member]                    
Common stock, shares authorized (in shares)               1,000,000,000    
Series A Preferred Stock [Member]                    
Preferred stock, shares issued (in shares)     6,237,500              
Preferred stock par value (in dollars per share)     $ 8.00              
Proceeds from issuance of preferred stock     $ 49.9              
Payments of stock issuance costs     $ 0.2              
Shares issued, Fair value         $ 40.0          
Series A Preferred Stock [Member] | Adimab Assignment Agreement [Member]                    
Preferred stock, shares issued (in shares)     5,000,000              
Series B Preferred Stock [Member]                    
Preferred stock, shares issued (in shares)       1,410,434            
Preferred stock par value (in dollars per share)       $ 56.72            
Proceeds from issuance of preferred stock       $ 80.0            
Payments of stock issuance costs       $ 0.2            
Series B Preferred Stock [Member] | Adimab Assignment Agreement [Member]                    
Preferred stock, shares issued (in shares)       44,076            
Shares issued, Fair value       $ 2.5            
Series C Preferred Stock [Member]                    
Preferred stock, shares issued (in shares)   4,296,550                
Preferred stock par value (in dollars per share)   $ 78.08578                
Proceeds from issuance of preferred stock   $ 335.5                
Payments of stock issuance costs   $ 0.3                
Preferred stock original issue and conversion price, per share           $ 78.08578        
Preferred stock, shares authorized (in shares)   4,296,550                
Series C Preferred Stock [Member] | Adimab Assignment Agreement [Member]                    
Preferred stock, shares issued (in shares)   128,064                
Shares issued, Fair value   $ 10.0